Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/09/2026 ,inter alia, to consider and approve To consider approve the proposal for raising funds through the issuance of equity shares, warrants convertible into equity shares, or other permitted instruments by way of preferential issue, private placement, rights issue or any combination.